Vous avez cherché: metaboliseringsenzymer (Danois - Anglais)

dette skyldes perikons inducering af metaboliseringsenzymer.
this is due to the induction of metabolising enzymes by st john’s wort.

virkningen skyldes, at perikon inducerer de medikamentelle metaboliseringsenzymer.
this is due to induction of drug metabolising enzymes by st john’s wort.

virkningen skyldes, at prikbladet perikum inducerer de medikamentelle metaboliseringsenzymer.
this is due to induction of drug metabolising enzymes by st john’ s wort.

bexaroten kan muligvis inducere metaboliseringsenzymer og derved teoretisk mindske østro- progestative præventionsmidlers virkning.
oral contraceptives: bexarotene can potentially induce metabolic enzymes and thereby theoretically reduce the efficacy of oestroprogestive contraceptives.

45 anden vej end efavirenz, og det er usandsynligt, at de vil konkurrere om de samme metaboliseringsenzymer og eliminationsveje.
nnrtis: no studies have been performed with efavirenz in combination with other nnrtis and the potential for pharmacokinetic or pharmacodynamic interactions is unknown.45 antimicrobial agents:

bimatoprost biotransformeres af flere enzymer og ad flere baner, og ingen virkninger på hepatisk lægemiddel metaboliseringsenzymer er observeret i førkliniske forsøg
bimatoprost is biotransformed by any of multiple enzymes and pathways, and no effects on hepatic drug metabolising enzymes were observed in preclinical studies.

bimatoprost biotransformeres af flere enzymer og ad flere baner, og ingen virkninger på hepatisk lægemiddel metaboliseringsenzymer er observeret i førkliniske studier.
bimatoprost is biotransformed by any of multiple enzymes and pathways, and no effects on hepatic drug metabolising enzymes were observed in preclinical studies.

orale præventionsmidler: bexaroten kan muligvis inducere metaboliseringsenzymer og derved teoretisk mindske østro-progestative præventionsmidlers virkning.
oral contraceptives: bexarotene can potentially induce metabolic enzymes and thereby theoretically reduce the efficacy of oestroprogestive contraceptives.

der forventes ingen klinisk signifikante interaktioner, da nrtier metaboliseres ad en anden vej end efavirenz, og det vil være usandsynligt, at disse vil konkurrere om de samme metaboliseringsenzymer og eliminationsveje.
clinically significant interactions are not expected since the nrtis are metabolised via a different route than efavirenz and would be unlikely to compete for the same metabolic enzymes and elimination pathways.

klinisk signifikante interaktioner forventes ikke, da nrti´ere metaboliseres ad en anden vej end efavirenz, og det er usandsynligt, at de vil konkurrere om de samme metaboliseringsenzymer og eliminationsveje.
clinically significant interactions would not be expected since the nrtis are metabolised via a different route than efavirenz and would be unlikely to compete for the same metabolic enzymes and elimination pathways.

103 anden vej end efavirenz, og det er usandsynligt, at de vil konkurrere om de samme metaboliseringsenzymer og eliminationsveje.nnrti'ere: der er ikke udført undersøgelser med efavirenz i kombination med andre nnrti'ere, og potentialet for farmakokinetiske eller farmakodynamiske interaktioner er ikke kendt.
nnrtis: no studies have been performed with efavirenz in combination with other nnrtis and the potential for pharmacokinetic or pharmacodynamic interactions is unknown.